| 1 |
|
NEOPLASIA - Abnormal rearrangement within the a/d T-cell receptor locus in lymphomas from Atm-deficient mice/
|
Liyanage, M
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 2 |
|
NEOPLASIA - Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10/
|
Cervenak, L
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 3 |
|
NEOPLASIA - A carboxy-terminal deletion mutant of Notch1 accelerates lymphoid oncogenesis in E2A-PBX1 transgenic mice/
|
Feldman, B J
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 4 |
|
NEOPLASIA - Acute myeloblastic leukemic cells acquire cellular cytotoxicity under genotoxic stress: Implication of granzyme B and perforin/
|
Bruno, A P
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 5 |
|
NEOPLASIA - Altered ligand binding and transcriptional regulation by mutations in the PML/RARa ligand-binding domain arising in retinoic-acid-resistant patients with acute promyelocytic leukemia/
|
C�t�, S
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 6 |
|
NEOPLASIA - Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes/
|
Aguayo, A
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 7 |
|
NEOPLASIA - An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus/
|
Foster, C B
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 8 |
|
NEOPLASIA - A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells/
|
Mochizuki, N
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 9 |
|
NEOPLASIA - Arsenic-interferon-a-triggered apoptosis in HTLV-I transformed cells is associated with Tax down-regulation and reversal of NF-kB activation/
|
El-Sabban, M E
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 10 |
|
NEOPLASIA - Bcr/Abl activates transcription of the Bcl-X gene through STAT5/
|
Gesbert, F
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 11 |
|
NEOPLASIA - Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines/
|
Jonuleit, T
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 12 |
|
NEOPLASIA - Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and a4b1-integrin enhances production of osteoclast-stimulating activity/
|
Michigami, T
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 13 |
|
NEOPLASIA - Cellular drug resistance profiles in childhood acute myeloid leukemia: Differences between FAB types and comparison with acute lymphoblastic leukemia/
|
Zwaan, C M
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 14 |
|
NEOPLASIA - CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs/
|
Fang, G
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 15 |
|
NEOPLASIA - Chronic lymphocytic leukemia B cells inhibit spontaneous Ig production by autologous bone marrow cells: Role of CD95-CD95L interaction/
|
Sampalo, A
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 16 |
|
NEOPLASIA - Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes/
|
Dierlamm, J
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 17 |
|
NEOPLASIA - Effective targeting of tumor vasculature by the angiogenesis inhibitors vasostatin and interleukin-12/
|
Yao, L
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 18 |
|
NEOPLASIA - Efficacy of ST1571, an Ab1 tyrosine kinase inhibitor, in conjunction with other antileukemic agents against Bcr-Abl-positive cells/
|
Thiesing, J T
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 19 |
|
NEOPLASIA - Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma/
|
Treon, S P
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 20 |
|
NEOPLASIA - European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: Histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes/
|
Anagnostopoulos, I
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|